Skip to main content
Abecma Approved for Earlier Lines in Relapsed/Refractory Multiple Myeloma
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Abecma Approved for Earlier Lines in Relapsed/Refractory Multiple Myeloma
User login
Username
Password
Reset your password
Concept
Lead
score
Multiple Myeloma
1
1
CAR-T
0
0.95
Biologic Therapy
0
0.86
Cytokines
0
0.37
Antigens
0
0.19
Cancer
0
0.19
Food and Drug Administration (FDA)
0
0.19
Lymphohistiocytosis
0
0.19
Monoclonal Antibody
0
0.19
Proteasome Inhibitor
0
0.19
Receptors
0
0.19
Refractory
0
0.19
Toxicology
0
0.18
Specialty
Lead
score
Hematology-Oncology
1
1
Edit Tags